0,995  0,002  Skin irritative effect
0,989  0,002  Eye irritation, high
0,920  0,002  GST A substrate
0,916  0,002  Cholesterol antagonist
0,911  0,003  Antihypercholesterolemic
0,884  0,004  Carcinogenic
0,861  0,004  Radioprotector
0,852  0,003  Vasodilator, peripheral
0,835  0,007  Caspase 9 stimulant
0,830  0,007  TNF expression inhibitor
0,814  0,004  Antithrombotic
0,797  0,009  Teratogen
0,789  0,003  Antiseptic
0,789  0,005  Mutagenic
0,797  0,016  Antiinflammatory
0,785  0,003  Glutathione S-transferase substrate
0,791  0,009  Embryotoxic
0,773  0,004  Spasmolytic
0,750  0,002  Aldehyde dehydrogenase inhibitor
0,750  0,005  NOS3 expression inhibitor
0,748  0,004  Histamine release inhibitor
0,746  0,003  Ulceration
0,723  0,004  Antipyretic
0,720  0,002  Antipruritic, allergic
0,720  0,005  Lipoprotein disorders treatment
0,717  0,003  Skeletal muscle relaxant
0,707  0,004  Antiglaucomic
0,704  0,010  Respiratory analeptic
0,694  0,002  VCAM1 expression inhibitor
0,685  0,002  Antihyperlipoproteinemic
0,684  0,005  Platelet antagonist
0,677  0,001  Endocannabinoid uptake inhibitor
0,677  0,002  GST P1-1 substrate
0,675  0,004  Hair growth stimulant
0,666  0,003  Mediator release inhibitor
0,673  0,017  Cyclophilin D inhibitor
0,673  0,017  Antidiabetic
0,660  0,009  Atherosclerosis treatment
0,648  0,010  Analeptic
0,639  0,005  Hypolipemic
0,635  0,004  Muscle relaxant
0,627  0,003  Phospholipase A2 inhibitor
0,620  0,003  Radiosensitizer
0,622  0,015  Chemoprotective
0,619  0,013  Sensitization
0,611  0,005  Vasodilator
0,618  0,015  Immunostimulant
0,602  0,004  Phospholipase C inhibitor
0,597  0,004  UGT1A3 substrate
0,604  0,012  UGT1A9 substrate
0,594  0,004  Non-steroidal antiinflammatory agent
0,611  0,028  CYP3A4 substrate
0,589  0,009  Hypoglycemic
0,580  0,003  Protein kinase stimulant
0,591  0,015  Antiallergic
0,583  0,012  Cardioprotectant
0,575  0,005  Antihypertriglyceridemic
0,570  0,004  UGT2B4 substrate
0,569  0,006  Platelet aggregation inhibitor
0,568  0,004  Alpha-N-acetylglucosaminidase inhibitor
0,579  0,016  Immunosuppressant
0,566  0,005  Antiulcerative
0,568  0,013  Apoptosis antagonist
0,569  0,016  CYP1A2 substrate
0,563  0,024  Aldehyde oxidase inhibitor
0,543  0,008  Antidiabetic symptomatic
0,537  0,011  Vasodilator, coronary
0,543  0,018  Immunomodulator
0,529  0,005  Muscular dystrophy treatment
0,539  0,017  Hepatic disorders treatment
0,576  0,055  Apoptosis agonist
0,539  0,022  5 Hydroxytryptamine release inhibitor
0,532  0,016  Antipsoriatic
0,506  0,002  Antipruritic, non-allergic
0,506  0,007  Monophenol monooxygenase inhibitor
0,500  0,005  Abortion inducer
0,503  0,010  Antihypoxic
0,508  0,023  Cytotoxic
0,491  0,011  Myocardial infarction treatment
0,493  0,019  NOS2 expression inhibitor
0,486  0,013  Angiogenesis stimulant
0,478  0,008  Diabetic retinopathy treatment
0,481  0,011  Antimutagenic
0,497  0,028  Bone diseases treatment
0,485  0,018  Antidiabetic (type 2)
0,482  0,020  Antihypertensive
0,489  0,029  CYP2C19 substrate
0,461  0,003  Toll-Like receptor 2 antagonist
0,460  0,004  Antieczematic
0,469  0,015  UGT1A6 substrate
0,462  0,009  Anesthetic
0,469  0,018  ICAM1 expression inhibitor
0,476  0,026  Antifungal
0,488  0,038  CYP2C9 substrate
0,454  0,007  Amylase inhibitor
0,449  0,008  UGT2B7 substrate
0,445  0,005  Interleukin 4 antagonist
0,453  0,014  Sedative
0,465  0,028  FMO1 substrate
0,439  0,007  GST M1-1 substrate
0,443  0,011  UGT1A4 substrate
0,467  0,036  Stroke treatment
0,436  0,009  Platelet adhesion inhibitor
0,447  0,020  Tumour necrosis factor alpha release inhibitor
0,431  0,005  Corneal wound healing stimulator
0,428  0,005  Insulin sensitizer
0,437  0,014  Interleukin agonist
0,446  0,023  Proliferative diseases treatment
0,436  0,014  Wound healing agent
0,421  0,010  Genotoxic
0,413  0,003  Alcohol dehydrogenase substrate
0,420  0,011  Melanin inhibitor
0,424  0,019  DNA synthesis inhibitor
0,405  0,005  Gastrin inhibitor
0,403  0,004  Vanilloid agonist
0,430  0,031  Antiosteoporotic
0,402  0,004  Antihelmintic (Nematodes)
0,402  0,005  CNS active muscle relaxant
0,431  0,040  5 Hydroxytryptamine release stimulant
0,390  0,002  Prostaglandin agonist
0,403  0,016  Anesthetic general
0,390  0,005  Expectorant
0,389  0,006  DNA polymerase I inhibitor
0,394  0,013  Diuretic
0,428  0,049  CYP2C19 inhibitor
0,411  0,033  Antioxidant
0,379  0,002  Lysophosphatidic acid 2 receptor antagonist
0,385  0,008  Alkylator
0,397  0,022  Vascular (periferal) disease treatment
0,432  0,057  Transcription factor NF kappa B inhibitor
0,415  0,040  Caspase 3 stimulant
0,399  0,028  Interleukin 2 agonist
0,450  0,079  Antineoplastic (solid tumors)
0,397  0,028  Chemopreventive
0,371  0,003  UGT2B10 substrate
0,371  0,004  Triose-phosphate isomerase inhibitor
0,389  0,022  UDP-glucuronosyltransferase substrate
0,431  0,064  Antibacterial
0,382  0,018  P-glycoprotein inhibitor
0,368  0,005  Succinate dehydrogenase inhibitor
0,376  0,013  Carcinogenic, group 3
0,400  0,037  CTGF expression inhibitor
0,370  0,007  Insulin secretagoues
0,396  0,034  Cytostatic
0,377  0,015  Hepatoprotectant
0,359  0,004  Adenylate kinase inhibitor
0,364  0,009  Antiparkinsonian, tremor relieving
0,360  0,009  Interleukin 6 antagonist
0,390  0,046  CYP2D6 substrate
0,362  0,022  RNA-directed DNA polymerase inhibitor
0,354  0,016  Skin whitener
0,339  0,004  Mucolytic
0,336  0,001  Antiviral (Parainfluenza)
0,331  0,001  Lysophosphatidic acid receptor 1 agonist
0,361  0,031  Antiparasitic
0,334  0,004  Calcium antagonist
0,332  0,004  Vanilloid 1 agonist
0,362  0,037  Interleukin antagonist
0,335  0,012  Antidote
0,328  0,005  Choleretic
0,323  0,000  Lysophosphatidic acid receptor 3 agonist
0,327  0,007  UGT2B1 substrate
0,324  0,005  Catalase inhibitor
0,354  0,037  Sodium/bile acid cotransporter inhibitor
0,326  0,010  Anesthetic local
0,341  0,026  Antiparkinsonian, rigidity relieving
0,340  0,025  Septic shock treatment
0,357  0,049  Lipoxygenase inhibitor
0,326  0,019  DNA methyltransferase I inhibitor
0,309  0,005  Antineoplastic, alkylator
0,344  0,042  Antiprotozoal (Leishmania)
0,340  0,040  Cardiodepressant
0,303  0,004  Leukotriene antagonist
0,315  0,018  Acaricide
0,321  0,025  Antiviral (Influenza)
0,352  0,056  AR expression inhibitor
0,362  0,067  Inflammatory Bowel disease treatment
0,336  0,041  Antineoplastic (endocrine cancer)
0,327  0,032  Cyclic AMP phosphodiesterase inhibitor
0,321  0,028  UGT1A1 substrate
0,344  0,052  Metabolic disease treatment
0,389  0,098  Antiarthritic
0,320  0,032  Antiarrhythmic
0,308  0,021  Antiacne
0,287  0,004  Keratolytic
0,288  0,006  Phosphofructokinase-1 inhibitor
0,292  0,010  Cell wall synthesis inhibitor
0,285  0,004  Sphingomyelinase inhibitor
0,289  0,011  Aldose reductase substrate
0,280  0,003  Arachidonic acid antagonist
0,295  0,018  Bone formation stimulant
0,295  0,019  CYP2B6 inhibitor
0,277  0,001  Lysophosphatidic acid 3 receptor antagonist
0,277  0,002  Prostaglandin E2 agonist
0,322  0,048  Cardiotonic
0,278  0,005  Transcription factor NF kappa B stimulant
0,282  0,009  Uterine stimulant
0,302  0,029  Antihypotensive
0,273  0,003  Toll-Like receptor 2 agonist
0,273  0,010  Antiviral (Poxvirus)
0,264  0,004  Adenylate cyclase stimulant
0,344  0,085  Toll-Like receptor agonist
0,308  0,049  Cardiovascular analeptic
0,265  0,008  Antifungal (Cryptococcus)
0,262  0,005  Gastric antisecretory
0,262  0,008  Antispirochetal
0,259  0,005  Antirickettsial
0,285  0,033  DNA methylase inhibitor
0,318  0,067  Antiischemic
0,289  0,039  Tyrosine 3 hydroxylase inhibitor
0,256  0,007  Microtubule formation inhibitor
0,269  0,020  Cystic fibrosis treatment
0,252  0,006  Aldehyde dehydrogenase substrate
0,269  0,025  Interferon gamma antagonist
0,262  0,021  Antipruritic
0,294  0,056  Transcription factor STAT3 inhibitor
0,273  0,038  Antihelmintic
0,254  0,022  Acute respiratory distress syndrome (ARDS) treatment
0,233  0,001  Prostaglandin EP2 agonist
0,276  0,045  Nitric oxide antagonist
0,230  0,004  Acyl-CoA dehydrogenase inhibitor
0,238  0,012  Retinoprotector
0,259  0,034  Neurotrophic factor enhancer
0,229  0,005  Histone deacetylase SIRT1 stimulant
0,229  0,005  Histone deacetylase stimulant
0,234  0,010  Antiviral (CMV)
0,226  0,004  Antidote, heavy metal
0,244  0,022  UGT2B9 substrate
0,241  0,019  Cholesterol synthesis inhibitor
0,227  0,005  Sphingosine 1-phosphate receptor 4 antagonist
0,251  0,032  Antiviral (Herpes)
0,269  0,052  Psychostimulant
0,231  0,016  Catenin beta inhibitor
0,223  0,008  Glutamate dehydrogenase inhibitor
0,233  0,022  Carcinogenic, group 1
0,213  0,003  UGT2B11 substrate
0,272  0,063  Antineoplastic (liver cancer)
0,214  0,005  Amidase inhibitor
0,219  0,011  Coagulant
0,213  0,007  Prolactin inhibitor
0,209  0,004  Prostaglandin F2 alpha antagonist
0,211  0,009  Antiviral (Influenza B)
0,232  0,031  Lipid peroxidase inhibitor
0,218  0,018  Antibacterial (Helicobacter pylori)
0,211  0,011  Arylamine N-Acetyltransferase substrate
0,219  0,020  Antineoplastic antimetabolite
0,217  0,020  Neurotrophic factor
0,200  0,004  Oleamide hydrolase inhibitor
0,231  0,034  Restenosis treatment
0,251  0,054  Antiviral (HIV)
0,199  0,004  Ca2+-transporting ATPase inhibitor
0,201  0,006  Interferon agonist
0,223  0,028  Neuropathy treatment
0,269  0,074  Transcription factor STAT inhibitor
0,218  0,025  ATPase inhibitor
0,197  0,004  Sphingosine 1-phosphate receptor 4 agonist
0,213  0,021  Cell adhesion inhibitor
0,192  0,002  Glucose-6-phosphate isomerase inhibitor
0,201  0,011  Sphingosine 1-phosphate receptor 5 antagonist
0,199  0,009  Antimetabolite
0,238  0,050  Peroxidase inhibitor
0,200  0,011  Selectin antagonist
0,193  0,005  Ornithine decarboxylase inhibitor
0,191  0,005  Neuraminidase (influenza) inhibitor
0,207  0,022  Raynaud's phenomenon treatment
0,191  0,007  Prostaglandin EP2 antagonist
0,187  0,004  Anticholelithogenic
0,189  0,007  Alcohol oxidase inhibitor
0,205  0,024  5-Lipoxygenase inhibitor
0,194  0,015  Contraceptive female
0,194  0,017  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,181  0,004  Thromboxane synthase inhibitor
0,181  0,005  Peroxisome proliferator-activated receptor alpha agonist
0,180  0,004  Leukotriene B4 antagonist
0,178  0,003  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,188  0,013  TRPA1 agonist
0,185  0,012  Actinic keratosis treatment
0,181  0,008  Carbamoyl phosphate synthetase inhibitor
0,261  0,090  Antineoplastic (multiple myeloma)
0,181  0,010  Thioredoxin inhibitor
0,179  0,010  Toll-Like receptor 4 antagonist
0,238  0,074  Free radical scavenger
0,197  0,036  Antidiabetic (type 1)
0,185  0,025  Cyclooxygenase 3 inhibitor
0,164  0,005  Neuraminidase inhibitor
0,173  0,013  Myasthenia Gravis treatment
0,201  0,042  UGT2B15 substrate
0,191  0,035  Antifungal enhancer
0,175  0,019  Photosensitizer
0,224  0,073  Peptidyltransferase inhibitor
0,163  0,012  Anabolic
0,173  0,023  UDP-glucose 4-epimerase inhibitor
0,159  0,012  Paget's disease treatment
0,157  0,009  Restless leg syndrome treatment
0,193  0,046  Antineoplastic (bone cancer)
0,155  0,010  Lanosterol 14 alpha demethylase inhibitor
0,157  0,011  Peroxisome proliferator-activated receptor gamma agonist
0,203  0,058  Growth hormone agonist
0,174  0,029  Aminopeptidase B inhibitor
0,154  0,012  Glutamate decarboxylase inhibitor
0,153  0,012  Antiviral (Rhinovirus)
0,232  0,092  DNA damaging
0,235  0,097  5 Hydroxytryptamine uptake stimulant
0,180  0,042  Renal failure treatment
0,148  0,011  Antiprotozoal activity enhancer
0,139  0,005  Thromboxane antagonist
0,142  0,009  Hyperparathyroidism treatment
0,152  0,019  Electron transport complex I inhibitor
0,144  0,013  Phenylalanine 4-hydroxylase inhibitor
0,184  0,053  Protein-tyrosine phosphatase inhibitor
0,172  0,043  Antianemic
0,142  0,013  Interleukin 5 antagonist
0,133  0,005  Aconitate hydratase inhibitor
0,240  0,112  FMO3 substrate
0,231  0,103  Renal disease treatment
0,131  0,004  Sphingosine kinase inhibitor
0,158  0,032  Sphingosine 1-phosphate receptor 2 antagonist
0,125  0,001  Prostaglandin F2 alpha agonist
0,146  0,024  Topoisomerase II alpha inhibitor
0,188  0,067  Diabetic nephropathy treatment
0,192  0,071  Sepsis treatment
0,125  0,005  Thromboxane A2 antagonist
0,129  0,010  Glycine receptor agonist
0,121  0,003  Leukotriene C antagonist
0,150  0,034  GABA C receptor agonist
0,119  0,004  Vanilloid 2 antagonist
0,212  0,097  Acute neurologic disorders treatment
0,138  0,023  GST T1-1 substrate
0,151  0,037  Menstruation disorders treatment
0,126  0,013  Na+ K+ transporting ATPase inhibitor
0,156  0,043  Protein-tyrosine phosphatase 1B inhibitor
0,135  0,022  NADH dehydrogenase inhibitor
0,171  0,059  Antiviral (Influenza A)
0,139  0,027  Folate antagonist
0,119  0,008  Interferon inducer
0,257  0,148  GABA C receptor rho-3 antagonist
0,127  0,017  CDC25A inhibitor
0,122  0,012  Ornithine carbamoyltransferase inhibitor
0,117  0,009  Antiviral (Herpesvirus 3, Human)
0,212  0,105  Superoxide dismutase inhibitor
0,110  0,005  Sphingosine 1-phosphate receptor agonist
0,121  0,016  Leukotriene synthesis inhibitor
0,148  0,043  Growth stimulant
0,126  0,021  Cell adhesion molecule inhibitor
0,171  0,067  Thrombolytic
0,131  0,028  Alcohol dehydrogenase inhibitor
0,123  0,021  Antifungal (Candida)
0,176  0,074  Lipocortins synthesis antagonist
0,111  0,009  Antimycoplasmal
0,104  0,004  Prostaglandin EP4 agonist
0,199  0,100  Antineoplastic (lymphocytic leukemia)
0,115  0,016  Ribonucleoside-diphosphate reductase inhibitor
0,105  0,007  Nitric oxide donor
0,158  0,059  Hemostatic
0,107  0,009  Gaucher disease treatment
0,102  0,004  Sphingosine 1-phosphate receptor 1 agonist
0,151  0,055  Toll-Like receptor antagonist
0,098  0,002  Lysophosphatidic acid 1 receptor antagonist
0,113  0,018  Ribonucleotide reductase inhibitor
0,133  0,040  HDL-cholesterol increasing
0,160  0,067  Hexokinase inhibitor
0,098  0,006  Adenosine deaminase inhibitor
0,245  0,152  Toll-Like receptor 7 agonist
0,109  0,017  Cannabinoid CB1 receptor agonist
0,098  0,007  Sphingosine 1-phosphate receptor 3 agonist
0,132  0,041  GABA C receptor antagonist
0,103  0,012  Autotaxin inhibitor
0,102  0,013  Acetyl-CoA transferase inhibitor
0,210  0,120  Antineoplastic (pancreatic cancer)
0,103  0,015  Vanilloid 4 agonist
0,097  0,009  Glucosylceramidase inhibitor
0,090  0,003  Leukotriene C4 antagonist
0,129  0,042  AMP-activated protein kinase stimulant
0,225  0,139  Antineoplastic (brain cancer)
0,093  0,007  Alpha-mannosidase inhibitor
0,145  0,059  Farnesoid X receptor antagonist
0,189  0,104  Antineoplastic (lymphoma)
0,129  0,046  Chelator
0,107  0,024  Lipase inhibitor
0,093  0,010  Sphingosine kinase 2 inhibitor
0,111  0,028  Glutathione S-transferase inhibitor
0,110  0,028  ATPase (Vacuolar H+) inhibitor
0,089  0,007  Mannosidase inhibitor
0,121  0,039  GABA C receptor rho-1 antagonist
0,133  0,054  Antiviral (Papilloma)
0,169  0,091  Antieczematic atopic
0,176  0,098  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,107  0,030  Hematopoietic
0,095  0,019  Antitreponemal
0,095  0,019  Beta adrenoreceptor antagonist
0,126  0,051  Caspase 3 inhibitor
0,078  0,004  Prostaglandin D2 agonist
0,091  0,017  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,101  0,027  Aminopeptidase I inhibitor
0,083  0,009  Anesthetic inhalation
0,121  0,048  Neutropenia treatment
0,092  0,019  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,150  0,078  Urolithiasis treatment
0,086  0,015  Beta 1 adrenoreceptor antagonist
0,106  0,035  Glutamate release inhibitor
0,134  0,064  Antihemorrhagic
0,078  0,008  Retinoid X receptor agonist
0,077  0,007  Fumarate hydratase inhibitor
0,122  0,052  Sphingosine 1-phosphate receptor 2 agonist
0,097  0,028  Estrogen-related receptor beta agonist
0,082  0,013  Lipocortins synthesis agonist
0,093  0,025  Elastase 1 inhibitor
0,101  0,033  Antiviral (Hepatitis A)
0,118  0,051  Acetylcholine release stimulant
0,121  0,054  Excitatory amino acid transporter EAAC1 inhibitor
0,073  0,006  Membrane dipeptidase inhibitor
0,138  0,072  Pancreatic disorders treatment
0,069  0,004  Prostacyclin agonist
0,067  0,002  Vitamin D receptor agonist
0,110  0,045  Electrolyte absorption antagonist
0,238  0,174  15-Lipoxygenase inhibitor
0,071  0,007  Neuraminidase (Influenza A) inhibitor
0,078  0,014  Sphingosine 1-phosphate receptor 1 antagonist
0,110  0,047  Potassium channel (Ca-activated) activator
0,120  0,058  Cystathionine beta-synthase inhibitor
0,068  0,006  Sphingosine kinase 1 inhibitor
0,079  0,018  Sphingosine 1-phosphate receptor 3 antagonist
0,079  0,018  Glycine transporter 2 inhibitor
0,153  0,095  Myocardial ischemia treatment
0,081  0,023  Glutamate (mGluR6) antagonist
0,182  0,124  Antineoplastic (renal cancer)
0,110  0,052  Carbonic anhydrase III inhibitor
0,112  0,054  Protease inhibitor
0,059  0,002  Thromboxane agonist
0,122  0,066  Antiprotozoal (Amoeba)
0,143  0,087  Movement disorders treatment
0,066  0,010  Phosphoglycerate kinase inhibitor
0,071  0,016  Sphingosine 1-phosphate receptor 5 agonist
0,084  0,029  Phospholipase D inhibitor
0,084  0,029  Peroxisome proliferator-activated receptor gamma antagonist
0,165  0,111  Growth factor agonist
0,097  0,043  ErbB-3 antagonist
0,092  0,038  Antibiotic
0,148  0,095  Liver fibrosis treatment
0,063  0,011  Squalene synthetase inhibitor
0,061  0,009  Leukotriene D4 antagonist
0,079  0,027  Exportin-1 inhibitor
0,119  0,068  Antifungal (Pneumocystis)
0,096  0,045  Tocolytic
0,172  0,121  Antiviral (Ebola)
0,097  0,048  Antineoplastic antibiotic
0,053  0,004  Calcium-independent phospholipase A2 inhibitor
0,063  0,015  Cholesterol esterase inhibitor
0,100  0,052  Phosphodiesterase 6D inhibitor
0,153  0,107  LDLR expression enhancer
0,052  0,006  HMG CoA reductase inhibitor
0,069  0,024  Cannabinoid CB2 receptor antagonist
0,073  0,029  Beta 3 adrenoreceptor antagonist
0,049  0,005  Elastase 2B inhibitor
0,049  0,005  Elastase 3B inhibitor
0,049  0,005  Elastase 3A inhibitor
0,054  0,010  Kainate receptor agonist
0,059  0,016  Microtubule stabilization
0,087  0,045  Carbonic anhydrase XIII inhibitor
0,055  0,012  Acetyl-CoA transferase 1 inhibitor
0,119  0,077  Cathepsin H inhibitor
0,101  0,059  Creatine kinase inhibitor
0,083  0,041  Sphingosine 1-phosphate receptor antagonist
0,044  0,002  Thromboxane A2 agonist
0,063  0,021  Beta 2 adrenoreceptor antagonist
0,167  0,126  Antiamyloidogenic
0,074  0,033  CDC25B inhibitor
0,065  0,023  Acetyl-CoA transferase 2 inhibitor
0,051  0,011  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,158  0,119  Anticonvulsant
0,067  0,028  Prostaglandin antagonist
0,041  0,003  Carbonic anhydrase VIII inhibitor
0,041  0,003  Carbonic anhydrase X inhibitor
0,063  0,025  Pregnane X receptor antagonist
0,070  0,032  Biliverdin reductase inhibitor
0,189  0,152  Prostate cancer treatment
0,181  0,145  Huntington's disease treatment
0,161  0,124  Pneumotoxic
0,070  0,034  Cannabinoid CB1 receptor antagonist
0,121  0,086  Antiprotozoal (Trichomonas)
0,044  0,010  Prostaglandin EP4 antagonist
0,079  0,045  GABA B receptor agonist
0,123  0,090  Psychosexual dysfunction treatment
0,138  0,107  Antianginal
0,100  0,070  Ferrochelatase inhibitor
0,141  0,111  Hearing loss treatment
0,185  0,155  Flavin-containing monooxygenase substrate
0,041  0,012  Hypoxanthine phosphoribosyltransferase inhibitor
0,041  0,011  Leukotriene B4 receptor 1 antagonist
0,115  0,085  Allergic rhinitis treatment
0,033  0,004  Isoleucine-tRNA ligase inhibitor
0,034  0,006  Calcium-sensing receptor antagonist
0,077  0,050  GABA aminotransferase inhibitor
0,044  0,017  Cholesterol absorption inhibitor
0,115  0,088  Gastritis treatment
0,118  0,092  Interleukin 1 antagonist
0,045  0,019  GABA uptake inhibitor
0,070  0,044  Protein kinase C alpha inhibitor
0,069  0,045  Potassium channel large-conductance Ca-activated activator
0,080  0,056  Glycine receptor antagonist
0,028  0,004  Calcium-dependent phospholipase A2 inhibitor
0,050  0,026  Purinergic P2Y antagonist
0,041  0,017  Prostacyclin antagonist
0,028  0,005  Neuraminidase (Influenza B) inhibitor
0,040  0,017  Peroxisome proliferator-activated receptor delta agonist
0,024  0,002  Mannitol 2-dehydrogenase inhibitor
0,037  0,015  ATP citrate lysase inhibitor
0,058  0,036  Maillard reaction inhibitor
0,093  0,072  Bronchodilator
0,070  0,049  Cannabinoid receptor antagonist
0,035  0,014  Uridine phosphorylase inhibitor
0,058  0,038  Argininosuccinate synthase inhibitor
0,100  0,080  SULT1A1 substrate
0,170  0,150  Antineoplastic (ovarian cancer)
0,090  0,072  Bile acid receptor antagonist
0,025  0,007  Toll-Like receptor 8 agonist
0,064  0,046  Protease 3C (Human rhinovirus) inhibitor
0,209  0,192  Antiasthmatic
0,122  0,105  Antiprotozoal (Coccidial)
0,026  0,009  Vitamin D receptor antagonist
0,029  0,012  Toll-Like receptor 4 agonist
0,044  0,027  Guanylate cyclase inhibitor
0,030  0,014  Prostaglandin H2 antagonist
0,091  0,075  Chronic obstructive bronchitis treatment
0,175  0,159  Antineurogenic pain
0,028  0,013  Purinergic P2Y12 antagonist
0,038  0,023  Nicotinic acid receptor agonist
0,088  0,074  Anticataract
0,061  0,047  Glucagon-like peptide 1 agonist
0,041  0,028  Thymidine kinase inhibitor
0,033  0,019  Prostaglandin EP3 antagonist
0,021  0,008  G-protein-coupled receptor 120 agonist
0,025  0,012  Leukotriene B4 receptor 2 antagonist
0,081  0,069  Antileprosy
0,061  0,049  Antiemphysemic
0,049  0,037  Squalene epoxidase inhibitor
0,036  0,024  Retinoid X alpha receptor agonist
0,034  0,023  Sodium-dependent vitamin C transporter 2 inhibitor
0,173  0,162  Amyotrophic lateral sclerosis treatment
0,053  0,042  Epithelial sodium channel blocker
0,038  0,028  Vanilloid 3 antagonist
0,015  0,005  Calcineurin inhibitor
0,077  0,069  Androgen antagonist
0,097  0,089  Antitussive
0,042  0,034  Geranyltranstransferase inhibitor
0,019  0,011  Methylmalonyl-CoA mutase inhibitor
0,118  0,111  SULT1A3 substrate
0,021  0,015  Peroxisome proliferator-activated receptor alpha antagonist
0,075  0,068  Antidote, organophosphates
0,180  0,174  12-Lipoxygenase inhibitor
0,073  0,067  Carbonic anhydrase VI inhibitor
0,025  0,020  Urotensin II agonist
0,103  0,099  Constipation treatment
0,030  0,026  Methionyl aminopeptidase 1 inhibitor
0,030  0,027  Calcitonin receptor agonist
0,034  0,031  Factor XIIIa inhibitor
0,027  0,024  1,3-Beta-glucan synthase inhibitor
0,024  0,021  Vanilloid 2 agonist
0,125  0,123  Pulmonary hypertension treatment
0,011  0,009  Immunosuppressant Cyclosporine-like
0,019  0,018  Retinoid X beta receptor antagonist
0,048  0,047  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,101  0,101  Shock treatment
0,015  0,014  Ileal bile acid transport inhibitor
0,011  0,011  Carbonic anhydrase XI inhibitor
0,044  0,044  Equilibrative nucleoside transport protein inhibitor
0,061  0,061  Histidine decarboxylase inhibitor

